TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Faun Pharma AS
Closing information (x1000 EUR)
Closing information | 2019/12 | 2018/12 | 2016/12 |
Turnover | 9,539 | 8,657 | 8,705 |
Financial expenses | 61 | 52 | 74 |
Earnings before taxes | 229 | -207 | 32 |
Total assets | 2,765 | 2,968 | 4,142 |
Current assets | 2,479 | 2,712 | 3,910 |
Current liabilities | 913 | 1,212 | 2,121 |
Equity capital | 235 | 6 | 90 |
- share capital | 101 | 100 | 110 |
Employees (average) | 30 | ||
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 | 2018/12 | 2016/12 |
Solvency | 8.5% | 0.2% | 2.2% |
Turnover per employee | 290 | ||
Profit as a percentage of turnover | 2.4% | -2.4% | 0.4% |
Return on assets (ROA) | 10.5% | -5.2% | 2.6% |
Current ratio | 271.5% | 223.8% | 184.3% |
Return on equity (ROE) | 97.4% | -3450.0% | 35.6% |
Change turnover | 736 | 771 | 3,484 |
Change turnover % | 8% | 10% | 67% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2019/12 | 2018/12 | 2016/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.